Alabama’s First Medical Cannabis Dispensary Launching in May 2024
The Alabama medical cannabis dispensary launch in May 2024 represents a historic step in expanding legal patient access. This launch introduces regulated cannabis access for qualifying patients under state oversight. Physicians and patients alike will…
Pascagoula City Council Expands Smoke-Free Ordinance to Include Cannabis and Vapes
The local cannabis smoke-free ordinance in Pascagoula now includes vaping devices and cannabis in public spaces. This expansion affects patient consumption patterns and clinical counseling. Healthcare providers should be aware of these evolving…
US System For Classifying Marijuana And Other Drugs Does ‘Immense Damage,’ Former DEA Official Says
The controlled substances act scheduling system critically affects marijuana research and patient access. Former DEA officials highlight how this system creates barriers to clinical practice. Understanding these impacts is essential for anticipating…
Scientists Gene Hacked a Plant to Produce Multiple Psychoactive Drugs
This article highlights biotechnology research psychedelics involving gene-hacked plants that produce multiple psychoactive compounds. The development may improve production consistency and cost-effectiveness. While promising, these compounds remain…
New York’s Growing Cannabis Treatment Gap and Access Barriers
Cannabis treatment access barriers in New York are creating significant challenges for patients seeking medical cannabis. These barriers contribute to healthcare inequities and limit patient access to licensed programs. Addressing these access issues is…
Ban on Rescue Dogs from High Rabies Risk Countries to Continue, CFIA Confirms
The CFIA's rabies prevention policy highlights public health risk management by banning rescue dogs from countries at risk. This regulatory approach prioritizes safety over access concerns. Understanding such policies aids cannabis clinicians in grasping…
State of Texas: Smokable Hemp Ban Takes Effect, Businesses Adapt
Texas hemp policy has shifted with the new smokable hemp ban, affecting patient access to inhaled CBD products. This ban limits rapid-onset options for acute symptom relief. Businesses in Texas are working to adapt to these regulatory changes.
7 Years After Legalization, Final Cannabis Licensing Lawsuit Goes to Court – Audacy
The cannabis licensing lawsuit highlights ongoing regulatory uncertainty impacting patient access to cannabis medicine. This legal dispute creates barriers for clinicians and patients relying on stable therapeutic supply chains. Understanding these…
Deusa Cast welcomes Colombian businessman from the cannabis sector
Colombian cannabis sector growth is reshaping international cannabis markets and supply chains. This development may influence global pricing and availability of medical cannabis products. Clinicians and industry stakeholders should monitor these changes…
How 2026 CBD Enforcement Policy Changes Are Shaping Cannabis Stocks
2026 CBD enforcement policy changes are reshaping the cannabis market landscape. Reduced FDA enforcement may improve patient access but raises concerns about product quality. Clinicians must guide patients on safe CBD use amid evolving regulations.
